Clinical Trials Logo

Neurofeedback clinical trials

View clinical trials related to Neurofeedback.

Filter by:

NCT ID: NCT06460207 Not yet recruiting - Cognitive Training Clinical Trials

Neurofeedback Removal of Emotional Information From Mind

remtrain
Start date: September 2024
Phase: N/A
Study type: Interventional

This project will examine whether individuals can be trained, using real-time feedback about brain function during neuroimaging, to effectively remove thoughts from mind by providing them with a sense of what it feels like to successfully remove a thought.

NCT ID: NCT05908253 Recruiting - Neurofeedback Clinical Trials

Toward a Generalizable Closed-loop Neurofeedback-based BCI for Attention Training

Start date: October 16, 2023
Phase: N/A
Study type: Interventional

The proposed study accelerates the translational aspect of neurofeedback-based attention training using novel technologies, algorithms, and neuromarkers. The presented brain training intervention and approaches will not only be applicable to attention remedy in patients with attention deficits but also can be applied to treatment of other neurocognitive (mental) disorders such as anxiety, depression, and addiction.

NCT ID: NCT05711550 Recruiting - Neurofeedback Clinical Trials

Investigating the Effect of Normal Frequency-band and Infra-low Frequency Neurofeedback on Functional Brain Connectome

Start date: January 13, 2023
Phase: N/A
Study type: Interventional

In this basic research project a novel form of neurofeedback is investigated, in which in addition to the use of 1) normal frequency bands (1-35 Hertz), 2) very slow signals (low frequency; < 0.1 Hertz) are used, which correspond more to the basic excitability of the brain. Because of the slow signal characteristics, this method is called infra-low frequency neurofeedback (ILF-NFB for short). Although this method has been successfully applied in clinical settings since the 1980s, the mechanisms underlying the effect are largely unexplored. For that purpose, a project consistiong of three studies will be conducted in order to investigate the neurophysiological effects of both signal elements on healthy participants: - Study 1 examines the effects of normal frequency band training alone. - Study 2 examines the effects of low frequency training. - Study 3 examines the effects of the combination of normal frequency band and low frequency training For each study, a total of 40 clean data sets are to be collected, resulting in a minimum amount of 120 participants for all three studies. All three studies investigate the effects of the neurofeedback on brain connectivity patterns by means of functional magnetic resonance imaging (fMRI), accompanied by measurements of the autonomic nervous system (ANS) and behavior.

NCT ID: NCT05518942 Terminated - Insomnia Clinical Trials

Effects of SMR Neurofeedback on Insomnia in Patients With Benign Brain Tumors

Start date: October 26, 2022
Phase: N/A
Study type: Interventional

Insomnia is the most common sleep disorder in patients with primary brain tumors. In the past, 21.5% to 59.2% of patients with primary brain tumors suffer from insomnia symptoms. In addition to hypnotics, nonpharmacological interventions for insomnia in patients with brain tumors are still lacking. When using hypnotics may cause daytime sleepiness, cognitive impairment, and increase the risk of cancer, seeking an effective intervention is of clinical importance. Sensorimotor rhythm neurofeedback therapy has been shown to improve insomnia in different populations. However, its effect on insomnia has not been explored in patients with brain tumors. We, therefore, aim to investigate the feasibility and effect of sensorimotor rhythm neurofeedback in improving insomnia in patients with benign brain tumors after surgery and to examine the correlation between the degree of insomnia improvement and quality of life changes after receiving sensorimotor rhythm neurofeedback.

NCT ID: NCT05254769 Recruiting - Clinical trials for Autism Spectrum Disorder

Neurofeedback Intervention in Children With Autism Spectrum Disorder (ASD)

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

This project aims to: - explore the effectiveness of Neurofeedback therapy for children diagnosed with Autism Spectrum Disorder (ASD) - assess if cognitive functions are affected before and after Neurofeedback Intervention

NCT ID: NCT04300933 Completed - Alzheimer Disease Clinical Trials

Neurofeedback Intervention for Preclinical Alzheimer's Disease

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD) is the most common form of neurodegenerative disorders leading to dementia. Currently, there has been no effective pharmacologic therapy for this disease. Electroencephalogram-based neurofeedback is considered as a potentially treatment strategy. In this project, the investigators aim to investigate the effectiveness of neurofeedback therapy on cognition for individuals with subjective cognitive decline (SCD). Participants will receive electroencephalogram-based neurofeedback therapy once a day for successive five days. Then, the investigators will evaluate the changes of memory function between baseline and post-therapy visits.

NCT ID: NCT04078438 Terminated - Depression Clinical Trials

Neurofeedback In Treatment Resistant Depression

Start date: June 27, 2014
Phase: N/A
Study type: Interventional

The investigators evaluate the effects of neurofeedback as an augmentation treatment on depressive symptoms and functional recovery in patients with treatment-resistant depression (TRD). TRD patients are assigned to the neurofeedback augmentation group and the medication-only (treatment as usual, TAU) group. The neurofeedback augmentation group underwent combined therapy comprising medication and 12-24 sessions of neurofeedback training for 12 weeks. To assess the serum levels of brain-derived neurotrophic factor (BDNF) in both groups, a pre- and post-treatment blood samples are obtained. Patients are evaluated using the Hamilton Depression Rating Scale (HAM-D), Beck Depression Inventory (BDI), Clinical Global Impression-Severity (CGI-S), 5-level version of European Quality of Life Questionnaire 5-Dimensional Classification (EQ-5D-5L), and Sheehan Disability Scale (SDS) at baseline, and at the 1-, 4-, and 12-week.

NCT ID: NCT04071717 Recruiting - Obesity Clinical Trials

Real-time NIRS Neurofeedback Regulating Brain Cognitive Function in Obese Individuals

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

To determine the efficacy of real-time fNIRS neurofeedback for regulating the brain cognitive function in obese individuals.

NCT ID: NCT04065906 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.

NCT ID: NCT03595293 Not yet recruiting - Clinical trials for Alcohol Use Disorder

fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD

Start date: January 1, 2026
Phase: N/A
Study type: Interventional

This study will examine the impact of functional near-infrared spectroscopy-based neurofeedback to a region within the brain's prefrontal cortex involved with self-regulation of resisting craving in alcohol use and prescription opioid use disorder patients. Participants will be asked to complete two cue reactivity tasks, six sessions of neurofeedback training as well as craving visual analog scales and self-efficacy questionnaires throughout a two-week period of their time in residential treatment at the Caron Treatment Center. They will be followed for 90 days after treatment completion at Caron to assess the impact neurofeedback had on their ability to remain sober once patients are living back in the "real world".